Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

130 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Hydrocortisone as an Intervention for Dexamethasone-Induced Adverse Effects in Pediatric Patients With Acute Lymphoblastic Leukemia: Results of a Double-Blind, Randomized Controlled Trial.
Warris LT, van den Heuvel-Eibrink MM, Aarsen FK, Pluijm SM, Bierings MB, van den Bos C, Zwaan CM, Thygesen HH, Tissing WJ, Veening MA, Pieters R, van den Akker EL. Warris LT, et al. J Clin Oncol. 2016 Jul 1;34(19):2287-93. doi: 10.1200/JCO.2015.66.0761. Epub 2016 May 9. J Clin Oncol. 2016. PMID: 27161966 Clinical Trial.
Development and validation of a prognostic multivariable model to predict insufficient clinical response to methotrexate in rheumatoid arthritis.
de Rotte MCFJ, Pluijm SMF, de Jong PHP, Bulatović Ćalasan M, Wulffraat NM, Weel AEAM, Lindemans J, Hazes JMW, de Jonge R. de Rotte MCFJ, et al. Among authors: pluijm smf. PLoS One. 2018 Dec 10;13(12):e0208534. doi: 10.1371/journal.pone.0208534. eCollection 2018. PLoS One. 2018. PMID: 30532219 Free PMC article.
Possible modification of BRSK1 on the risk of alkylating chemotherapy-related reduced ovarian function.
van der Kooi ALF, van Dijk M, Broer L, van den Berg MH, Laven JSE, van Leeuwen FE, Lambalk CB, Overbeek A, Loonen JJ, van der Pal HJ, Tissing WJ, Versluys B, Bresters D, Beerendonk CCM, Ronckers CR, van der Heiden-van der Loo M, Kaspers GL, de Vries ACH, Robison LL, Hudson MM, Chemaitilly W, Byrne J, Berger C, Clemens E, Dirksen U, Winther JF, Fosså SD, Grabow D, Haupt R, Kaiser M, Kepak T, Kruseova J, Modan-Moses D, Pluijm SMF, Spix C, Zolk O, Kaatsch P, Krijthe JH, Kremer LC, Yasui Y, Brooke RJ, Uitterlinden AG, van den Heuvel-Eibrink MM, van Dulmen-den Broeder E. van der Kooi ALF, et al. Among authors: pluijm smf. Hum Reprod. 2021 Mar 18;36(4):1120-1133. doi: 10.1093/humrep/deaa342. Hum Reprod. 2021. PMID: 33582778 Free PMC article.
Clinical evaluation of late outcomes in Dutch childhood cancer survivors: Methodology of the DCCSS LATER 2 study.
Feijen EAM, Teepen JC, van Dulmen-den Broeder E, van den Heuvel-Eibrink MM, van der Heiden-van der Loo M, van der Pal HJH, de Vries ACH, Louwerens M, Bresters D, Versluys B, de Ridder H, Veening M, van Leeuwen FE, Grootenhuis M, Maurice-Stam H, van Santen HM, Neggers SJCMM, Pluijm S, den Hartogh J, Ronckers CM, Tissing WJE, Loonen JJ, Kremer LCM. Feijen EAM, et al. Pediatr Blood Cancer. 2023 May;70(5):e30212. doi: 10.1002/pbc.30212. Epub 2023 Jan 18. Pediatr Blood Cancer. 2023. PMID: 36651687
Physical frailty deteriorates after a 5-day dexamethasone course in children with acute lymphoblastic leukemia, results of a national prospective study.
Verwaaijen EJ, van Hulst AM, Hartman A, Pieters R, Fiocco M, Pluijm SMF, van Litsenburg RRL, Grootenhuis MA, van den Akker ELT, van den Heuvel-Eibrink MM. Verwaaijen EJ, et al. Among authors: pluijm smf. Cancer Med. 2023 Dec;12(24):22304-22315. doi: 10.1002/cam4.6779. Epub 2023 Dec 9. Cancer Med. 2023. PMID: 38069550 Free PMC article.
Unhealthy lifestyle behaviors, overweight, and obesity among childhood cancer survivors in the Netherlands: A DCCSS LATER study.
Bouwman E, Penson A, de Valk M, van den Oever SR, van der Pal HJH, van Dulmen-den Broeder E, Blijlevens NMA, Bresters D, Feijen EAM, van den Heuvel-Eibrink MM, van der Heiden-van der Loo M, Michel G, Ronckers CM, Teepen JC, Tissing WJE, Versluys BAB, Kremer LCM, Pluijm SMF, Loonen JJ; Dutch LATER Study Group and the PanCareFollowUp Consortium. Bouwman E, et al. Among authors: pluijm smf. Cancer. 2024 Aug 15;130(16):2856-2872. doi: 10.1002/cncr.35338. Epub 2024 Apr 25. Cancer. 2024. PMID: 38662406
Treatments affecting splenic function as a risk factor for valvular heart disease in Childhood Cancer Survivors: A DCCSS-LATER study.
Houtman BM, Walraven I, Kapusta L, Teske AJ, van Dulmen-den Broeder E, Tissing WJE, van den Heuvel-Eibrink MM, Versluys ABB, Bresters D, van der Heiden-van der Loo M, Ronckers C, Kok WEM, van der Pal HJH, Pluijm SMF, Janssens GO, Blijlevens NMA, Kremer LCM, Loonen JJ, Feijen EAML. Houtman BM, et al. Among authors: pluijm smf. Pediatr Blood Cancer. 2024 Nov;71(11):e31251. doi: 10.1002/pbc.31251. Epub 2024 Aug 12. Pediatr Blood Cancer. 2024. PMID: 39135313
130 results